Main Article Content


Orofacial neuropathic pain happens due to somatosensory nervous system injury or disease in the orofacial region. Multiple types of orofacial neuropathic pain have been identified, including nonodontogenic neuropathic orofacial pain, postherpetic neuralgia, atypical odontalgia, glossopharyngeal neuralgia and trigeminal neuralgia. Currently, pharmacological intervention is well known as the foundation for managing neuropathic pain. Drugs from different classifications, including anticonvulsants, antidepressants, opioids, and nonsteroidal anti-inflammatory drugs, are generally used to treat these events. However, these drugs are not yet broadly accepted for these treatments. This review will explore recent clinical findings and fragments of evidence regarding anticonvulsants and antidepressants in the management of trigeminal neuralgia.

Andres Felipe Aguirre Osorio, a:1:{s:5:"en_US";s:24:"Prosthodontics registrar";}

University of Sydney, Department of Prosthodontic, Sydney, New South Wales, Australia

Aguirre Osorio, A. F. (2023). Trigeminal Neuralgia: Anticonvulsants and Antidepressants . Revista Estomatología, 31(2).

Crandall JA. An Introduction to Orofacial Pain. Dent Clin North Am. 2018;62(4):511-23. DOI:

Balasubramaniam R, Klasser GD. Orofacial pain syndromes: evaluation and management. Med Clin North Am. 2014;98(6):1385-405. DOI:

Ghurye S, McMillan R. Orofacial pain - an update on diagnosis and management. Br Dent J. 2017;223(9):639-47. DOI:

Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments. Mol Pain. 2020;16:1744806920901890. DOI:

Jessri M, Sultan AS, Tavares T, Schug S. Central mechanisms of pain in orofacial pain patients: Implications for management. J Oral Pathol Med. 2020;49(6):476-83. DOI:

Jones MR, Urits I, Ehrhardt KP, Cefalu JN, Kendrick JB, Park DJ, et al. A comprehensive review of trigeminal neuralgia. Current pain and headache reports. 2019;23(10):1-7. DOI:

Prasad S, Galetta S. Trigeminal Neuralgia: Historical Notes and Current Concepts. The Neurologist (Baltimore, Md). 2009;15(2):87-94. DOI:

Reddy GDMDP, Viswanathan AMD. Trigeminal and Glossopharyngeal Neuralgia. Neurologic clinics. 2014;32(2):539-52. DOI:

Rozen TD. Trigeminal neuralgia andglossopharyngeal neuralgia. Neurologic clinics. 2004;22(1):185-206. DOI:

Cruccu G, Finnerup NB, Jensen TS, Scholz J, Sindou M, Svensson P, et al. Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology. 2016;87(2):220-8. DOI:

Al-Quliti KW. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options. Neurosciences (Riyadh, Saudi Arabia). 2015;20(2):107-14. DOI:

Bendtsen L, Zakrzewska J, Abbott Ja, Braschinsky M, Di Stefano G, Donnet A, et al. European Academy of Neurology guideline on trigeminal neuralgia. European journal of neurology. 2019;26(6):831-49. DOI:

Keppel Hesselink JM, Schatman ME. Phenytoin and carbamazepine in trigeminal neuralgia: marketing-based versus evidence-based treatment. Journal of pain research. 2017;10:1663-6. DOI:

Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European journal of neurology. 2010;17(9):1113-e88. DOI:

Bazzari FH, Bazzari AH. Orofacial neuropathic pain : a pharmacological approach. SA Pharmaceutical Journal. 2019;86(4):23-8.

Clark G. Evidence-Based Pharmacologic Approaches for Chronic Orofacial Pain. J Calif Dent Assoc. 2015;43(11):643-54. DOI:

Dexter M, Aggarwal A. Medical, pharmacological and neurosurgical perspectives on trigeminal neuralgia. Australian Endodontic Journal. 2018;44:136-47. DOI:

Maarbjerg S, Benoliel R. The changing face of trigeminal neuralgia—A narrative review. Headache. 2021;61(6):817-37. DOI:

Phillip Siddall RD. Advance Studies in Orofacial Pain: Module 2: Neuropathic Orofacial Pain. University of Sydney | All rights reserved. 2019;V1.

Vargas-Espinosa ML, Sanmartí-García G, Vázquez-Delgado E, Gay-Escoda C. Antiepileptic drugs for the treatment of neuropathic pain: a systematic review. Medicina Oral, Patología Oral y Cirugía Bucal. 2012;17(5):e786. DOI:

Qin Z, Xie S, Mao Z, Liu Y, Wu J, Furukawa TA, et al. Comparative efficacy and acceptability of antiepileptic drugs for classical trigeminal neuralgia: a Bayesian network meta-analysis protocol. BMJ open. 2018;8(1):e017392-e. DOI:

Zilliox LA. Neuropathic pain. CONTINUUM: Lifelong Learning in Neurology. 2017;23(2):512-32. DOI:

Benoliel R, Eliav E. Neuropathic orofacial pain. Alpha Omegan. 2012;105(3-4):66-74.

Zakrzewska JM, Akram H. Neurosurgical interventions for the treatment of classical trigeminal neuralgia. Cochrane Database of Systematic Reviews. 2011(9). DOI:

Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. The Clinical journal of pain. 2002;18(1):4-13. DOI:

Liu M, Zhong J, Xia L, Dou N, Li S. The expression of voltage-gated sodium channels in trigeminal nerve following chronic constriction injury in rats. International Journal of Neuroscience. 2019;129(10):955-62. DOI:

O'Connor ABMDMPH, Dworkin RHP. Treatment of Neuropathic Pain: An Overview of Recent Guidelines. The American journal of medicine. 2009;122(10):S22-S32. DOI:

Romero-Reyes M, Uyanik JM. Orofacial pain management: current perspectives. Journal of Pain Research. 2014;7:99-115. DOI:

Tricyclic antidepressants (TCAs) are first-line drugs for the treatment of neuropathic pain, but their mechanisms of action in this context are unclear. Nature reviews Neurology. 2009;5(5):238.

An update on the drug treatment of neuropathic pain. Part 1: antidepressants. Drug and therapeutics bulletin. 2012;50(10):114-93. DOI:

Renton T. Chronic orofacial pain. Oral diseases. 2017;23(5):566-71. DOI:

Di Stefano G, Truini A, Cruccu G. Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. Drugs (New York, NY). 2018;78(14):1433-42. DOI:

An update on the drug treatment of neuropathic pain. Part 2: antiepileptics and other drugs. Drug and Therapeutics Bulletin. 2012;50(11):126. DOI:

Zakrzewska JM. Medical management of trigeminal neuropathic pains. Expert opinion on pharmacotherapy. 2010;11(8):1239-54. DOI:

Sansone RA, Sansone LA. Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgmont). 2008;5(12):16-9.

Cardoso FC, Schmit M, Kuiper MJ, Lewis RJ, Tuck KL, Duggan PJ. Inhibition of N-type calcium ion channels by tricyclic antidepressants - experimental and theoretical justification for their use for neuropathic pain. RSC Med Chem. 2022;13(2):183-95. DOI:

Schimmel M, Aarab G, Baad-Hansen L, Lobbezoo F, Svensson P. A conceptual model of oro-facial health with an emphasis on function. J Oral Rehabil. 2021;48(11):1283-94. DOI:

Zakrzewska JM. Multi-dimensionality of chronic pain of the oral cavity and face. J Headache Pain. 2013;14(1):37-. DOI:

Halpern L, Willis P. Orofacial Pain: Pharmacologic Paradigms for Therapeutic Intervention. Dent Clin North Am. 2016;60(2):381-405. DOI:

Lambru G, Zakrzewska J, Matharu M. Trigeminal neuralgia: a practical guide. Pract Neurol. 2021;21(5):392-402. DOI:

Edwards RR, Dworkin RH, Sullivan MD, Turk DC, Wasan AD. The Role of Psychosocial Processes in the Development and Maintenance of Chronic Pain. J Pain. 2016;17(9 Suppl):T70-T92. DOI:

Roditi D, Robinson ME. The role of psychological interventions in the management of patients with chronic pain. Psychol Res Behav Manag. 2011;4:41-9. DOI:

Received 2023-03-08
Accepted 2023-10-06
Published 2023-10-06